title: Evolution of protease and reverse transcriptase inhibitor resistance-associated mutations in HIV-1-infected protease inhibitor-treated patients with persistent low viraemia.
authors.forename: Xavier
authors.initials: X
authors.lastname: Duval
authors.forename: Diane
authors.initials: D
authors.lastname: Descamps
authors.forename: Guillaume
authors.initials: G
authors.lastname: Breton
authors.forename: Sophie
authors.initials: S
authors.lastname: Darmon
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Ecobichon
authors.forename: Séverine
authors.initials: S
authors.lastname: Delarue
authors.forename: Gilles
authors.initials: G
authors.lastname: Peytavin
authors.forename: Catherine
authors.initials: C
authors.lastname: Leport
authors.forename: Jean-Louis
authors.initials: JL
authors.lastname: Vildé
authors.forename: Françoise
authors.initials: F
authors.lastname: Brun-Vézinet
mesh_terms: D023241:Antiretroviral Therapy, Highly Active; D024882:Drug Resistance, Viral / Q000235:genetics; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D017320:HIV Protease Inhibitors / Q000494:pharmacology*; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics*; D006801:Humans; D009154:Mutation; D012189:Retrospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology*; D014766:Viremia / Q000188:drug therapy / Q000821:virology
chemical_list: D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors